Epilepsy is an ancient disease known in humans and is a worldwide public health problem affecting more than 50 million people. There are various approaches proposed to manage the disease.
Cases of drug-resistant epilepsy, also known as refractory epilepsy, are increasing worldwide despite new drug developments. This increase is outpacing how quickly we can come out with new therapies. Anti-seizure medications are the go-to and most widely used treatment for epilepsy; however, approximately 30 to 40 percent of people have drug-resistant epilepsy. Over the past many decades, three invasive neuromodulation devices for treating refractory epilepsy have been approved by the Food and Drug Administration.
Read more at: https://www.galvnews.com/health/free/article_cc80c4f3-054a-58b3-84c8-cf121f6fb265.html